THERASPHERE Y-90 Glass Microspheres ™


MAKE MOVE


A CALCULATED The evidence1 proves that personalized


dosimetry has a high correlation with improved response and overall survival in patients with HCC. Only TheraSphere equips you with a personalized, custom-prepared dose that arrives in a vial ready to deploy.


Customize the dose, maximize your results.


www.TheraSphere.com


Ple int 


n e al ra  


in


lease se nterna


  ee in de ba  


nsid b ck coveover o n adiation therapy n patie


y in e ffor Indica ations, Cont      


ients wi  


ntraindications, Warnings, Precautions,Adverse Events, and Operator’s Instructions. Rx Only. 1. Garin E, Ts kaseli w tht lol calc ly advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised,multicentre, open-label phase 2


L, Guiu B et al. Personalized versus standard dosimetry approach of selectivef


tria .l. Lancet Gastroenterol Hepatol. 2021, 6: 17-29. TheraSphere is a registered trademark 


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20